EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC-SA 4.0

Global, regional, and national burdens: An overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains

Shuaibu Suleiman Adeiza, Md. Aminul Islam, Aminu Shittu

One Health Bulletin · 2024-12 · 4 (4) · 164-180

DOI: 10.4103/ohbl.ohbl_10_24 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift One Health Bulletin, online erschienen am 05.07.2024. Verfasst von Shuaibu Suleiman Adeiza und 2 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To provide an inclusive blend of extant meta-analyses on the burden of Staphylococcus ( S. ) aureus and its resistant strains across diverse study populations, settings, and temporal contexts.

Methods

The study has adopted PRISMA 2020-based guides and registered its protocol on Open Science Framework with an extensive literature search. Study quality was assessed by QUOROM and AMSTAR techniques. Data analysis included parsing of study-level statistical power, assessment of primary study overlap, pooling of meta-analysis results, subgroup and temporal analysis.

Results

Totally 41 studies (64 meta-analyses) were selected by the inclusion criteria. The summary meta-analysis revealed global prevalence rates for S. aureus [24.8%, 95%C1 0.248(0.204-0.293), I2 = 93%], methicillin resistant S. aureus (MRSA) [5.8%, 95% CI 0.058(0.044-0.073), I2 = 92%], vancomycin intermediate S. aureus [1.7%, 95%C1 0.017(0.013–0.021), I2 = 36.4%], heterogeneous vancomycin intermediate S. aureus [5.2%, 95% CI 0.052(0.038–0.056), I2 = 36.4%], community-associated methicillin-resistant S. aureus [19.9%, 95%C1 0.199(-0.170–0.568), I2 = 96.67%), livestock-associated-MRSA [13.6%, 95% CI 0.136(-0.028–0.243), I2 = 97.7%], and mupirocin resistant S. aureus [7.6%, 95% CI 0.076(0.062–0.090), 12 = 0%]. Temporal analysis revealed that the burden community-associated methicillin-resistant S. aureus notably increased from 1.3% in 2003 to 39.0% in 2014. Coagulase-negative staphylococci rose from 23.2% in 2021 to 29.8% in 2022. Vancomycin resistant S. aureus peaked at 9.0% in 2018, declining to 2.6% in 2020. Livestock-associated-MRSA significantly increased to 19.0% in 2020. MRSA fluctuated, peaking at 52.7% in 2012 and 31.0% in 2022.

Conclusions

The study reveals a considerable global prevalence of S. aureus at 24.8%. Regional differences were apparent, with Africa facing a high burden of MRSA at 40.8% of S. aureus and temporal trends exposed a dynamic state.

Zitieren

APA

Adeiza, S. S., Islam, M. A., & Shittu, A. (2024). Global, regional, and national burdens: An overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains. One Health Bulletin, 4(4), 164-180. https://doi.org/10.4103/ohbl.ohbl_10_24

Vancouver

Adeiza SS, Islam MA, Shittu A. Global, regional, and national burdens: An overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains. One Health Bulletin. 2024;4(4):164-180. doi:10.4103/ohbl.ohbl_10_24

BibTeX
@article{Adeiza2024,
  author = {Adeiza, Shuaibu Suleiman and Islam, Md. Aminul and Shittu, Aminu},
  title = {Global, regional, and national burdens: An overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains},
  journal = {One Health Bulletin},
  year = {2024},
  volume = {4},
  number = {4},
  pages = {164--180},
  doi = {10.4103/ohbl.ohbl_10_24}
}
Kostenlos starten →